COMPARISON OF IN VITRO CHARACTERISTICS OF TWO UK MESALAZINE 400MG PRODUCTS
- Investigation of the Enteric Pathogenic Potential of Oral Campylobacter concisus Strains Isolated from Patients with Inflammatory Bowel Disease. Ismail, Yazan; Mahendran, Vikneswari; Octavia, Sophie; Day, Andrew S.; Riordan, Stephen M.; Grimm, Michael C.; Lan, Ruiting; Lemberg, Daniel; Thi Anh Tuyet Tran; Li Zhang // PLoS ONE;May2012, Vol. 7 Issue 5, p1
Background: Campylobacter concisus, a bacterium colonizing the human oral cavity, has been shown to be associated with inflammatory bowel disease (IBD). This study investigated if patients with IBD are colonized with specific oral C. concisus strains that have potential to cause enteric...
- Probiotics and Immune Regulation of Inflammatory Bowel Diseases. Y. Cong; A. Konrad; N. Iqbal; C.O. Elson // Current Drug Targets - Inflammation & Allergy;Jun2003, Vol. 2 Issue 2, p145
Intestinal microflora play an important role in the pathogenesis of inflammatory bowel diseases (IBD). Certain probiotic bacteria provide beneficial effects for human health and intervention of IBD. Possible mechanisms underlying these effects are diverse and include many aspects of the...
- Inflammatory Bowel Disease. // Current Medical Literature: Gastroenterology;2003, Vol. 22 Issue 2, p54
Presents citations and clinicians' notes about inflammatory bowel disease. 'High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease,' by J. Klaus, G. Armbrecht et al.; 'Primary chronic interstitial nephritis in Crohn's disease,' by H. Izzedine, J. Simon et al.
- The treatment of inflammatory bowel disease in children. Wyllie, Robert; Sarigol, Samra // Clinical Pediatrics;Jul1998, Vol. 37 Issue 7, p421
Editorial. Discusses the treatment of inflammatory bowel disease in children. Symptoms of inflammatory bowel disease; Efficacy of metronidazole; Study on corticosteroid analogues; Nutritional intervention in Crohn's disease.
- Inflammatory bowel disease. Galper, Charlotte; Cerda, James; Hanauer, Stephen B.; Peppercorn, Mark A.; Wexner, Steven D. // Patient Care;3/15/1998, Vol. 32 Issue 5, p81
Focuses on treatments for inflammatory bowel diseases (IBDs). Detailed information on ulcerative colitis (UC), crohn's disease (UC) and their treatments; Reference to nutritional therapy; Precautions with the use of corticosterioids for IBD patients; Indepth look at several therapies for IBD. ...
- Prevalence of inflammatory bowel disease in British 26... Montgomery, S. M.; Morris, D. L.; Thompson, N.P.; Subhani, J.; Pounder, R.E.; Wakefield, A.J. // BMJ: British Medical Journal (International Edition);04/04/98, Vol. 316 Issue 7137, p1058
Presents information on a study investigating the prevalence of inflammatory disease in British 26 years olds. Characteristics of the subjects of the study; Methodology used in the study; Statistics on the result of the study.
- Clarifications. Leidel, Jan // Deutsches Aerzteblatt International;12/9/2011, Vol. 108 Issue 49, p836
A letter to the editor is presented in response to the article "Vaccination Coverage in Immunosuppressed Patients--Results of a Regional Health Services Research Study," by Niels Teich and colleagues in the 2001 issue.
- Technetium-99m autologous phagocyte scanning: a new imaging technique for inflammatory bowel disease. pullman, W.; Hanna, R.; Sullivan, P.; Booth, J.A.; Lomas, F.; Doe, William F. // British Medical Journal (Clinical Research Edition);7/19/1986, Vol. 293 Issue 6540, p171
Examines the use of technetium (Tc)-99m autologous phagocyte scanning in determining the inflammatory bowel disease. Occurrence of terminal ileal Crohn's disease; Detection of mucosal inflammation; Advantages of Tc phaghocyte scan.
- Bacteroides fragilis Enterotoxin Gene Sequences in Patients with Inflammatory Bowel Disease. Prindiville, Thomas P.; Sheikh, Rafik A.; Cohen, Stuart H.; Tang, Yajarayma J.; Cantrell, Mary C.; Silva Jr., Joseph // Emerging Infectious Diseases;Mar/Apr2000, Vol. 6 Issue 2, p171
We identified enterotoxigenic Bacteroides fragilis in stool specimens of patients with inflammatory bowel disease and other gastrointestinal disorders. The organism was detected in 11 (13.2%) of 83 patients with inflammatory bowel disease. Of 57 patients with active disease, 19.3% were toxin...